EDGAR Filing Documents for 0001193125-10-067202

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-10-067202

Filing Date

2010-03-25

Accepted

2010-03-25 16:50:28

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q (12/31/2008)	d10q.htm	10-Q	997680
2	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)	dex311.htm	EX-31.1	9974
3	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)	dex312.htm	EX-31.2	10118
4	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	4993
5	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	5457
	Complete submission text file	0001193125-10-067202.txt		1029600

Mailing Address 2503 S HANLEY RD ST LOUIS MO 63144

Business Address 2503 S HANLEY RD ST LOUIS MO 63144 3146456600

KV PHARMACEUTICAL CO /DE/ (Filer) CIK: 0000057055 (see all company filings)